Influenza Diagnostics Market to Grow At a CAGR of 8.45% during the Period 2014 – 2023

Industry Trend Analysis:
The Influenza Diagnostics Market was worth USD 0.42 billion in 2014 and is expected to reach approximately USD 0.88 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.45% during the forecast period.

Browse Full Report @ https://www.crystalmarketresearch.com/report/influenza-diagnostics-market .

Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza.

Test Type Outlook and Trend Analysis:
According to the Type the market of Influenza Diagnostics is divided into Traditional and Molecular. Rapid Influenza Detection Test (RIDT) constituted the major share of the market due to its benefits such as quick results, user friendly, etc. The RIDT is expected to continue growing during the forecast period. The Molecular test types segment is also further divided into Nucleic Acid Sequence-Based Amplification (NASBA), RT-PCR, Loop-Mediated Isothermal Amplification-Based Assays (LAMP), and Simple Amplification-Based Assays (SAMBA). Due to its ability to distinguish between Influenza A & B viruses the RT-PCR is the most widely used Molecular test.

Get Sample Copy of This Report @ https://www.crystalmarketresearch.com/report-sample/HC04719 .

Regional Outlook and Trend Analysis:
According to the region, the Influenza Diagnostics Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The Europe regions accounts to the majority of the share in the Influenza Diagnostics Market due to increasing population and also rising incidents of influenza diseases. The North-America region is the second largest market for Influenza Diagnostics followed by Asia-Pacific which is expected to grow at the highest CAGR during the forecast owing to increased expenditure, rising influenza incidents, etc.

End User Method Outlook and Trend Analysis:
The End-User segment is fragmented into Hospitals & Clinics, Reference lab, POC, Home Care Agency. The Hospitals and Clinics segments amongst the End-User segments are prominent due to extensive use of these tests in diagnostics of influenza which are mostly carried out there.

The Influenza Diagnostics Market is segmented as follows-
By Natural Test Type:
Traditional Viral Culture
Serology Test
Rapid Influenza Detection Test
DFA

By Molecular Test Type:
Nucleic Acid Sequence-Based Amplification (NASBA)
RT-PCR
Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-Based Assays (SAMBA)

By End User:
Hospital
Clinic
Reference lab
POC
Home Care Agency

Competitive Insights:
The leading players in the market are Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company.

Make an Inquiry @ https://www.crystalmarketresearch.com/send-an-enquiry/HC04719 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
RSS/Feeds: https://www.crystalmarketresearch.com/feed/latestreports.xml